Results 1 to 10 of about 63,993 (197)

Pharmacovigilance: An Overview [PDF]

open access: yesClinical Therapeutics, 2018
Pharmacovigilance (PV) is a relatively new discipline in the pharmaceutical industry. Having undergone rapid growth over the past 2 decades, PV now touches many other disciplines in the research and development enterprise. With its growth has come a heightened awareness and interest in the medical community about the roles that PV plays.
Paul Beninger
exaly   +3 more sources

Pharmacovigilance system in Saudi Arabia

open access: yesSaudi Pharmaceutical Journal, 2017
Pharmacovigilance plays an important role in ensuring that patients are receiving safe drugs. In Saudi Arabia, Saudi Food and Drug Authority, health institutions, marketing authorization holders and healthcare professional are involved in ...
Thamir M Alshammari   +2 more
exaly   +3 more sources

Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers

open access: yesБезопасность и риск фармакотерапии, 2021
Ensuring the safety of pharmacotherapy is a priority of the national regulatory health policy and is enshrined in the international and federal legislation.
A. E. Krasheninnikov   +2 more
doaj   +1 more source

Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature

open access: yesFrontiers in Immunology, 2023
BackgroundAlbeit the need for sex-disaggregated results of adverse events after immunization (AEFIs) is gaining attention since the COVID-19 pandemic, studies with emphasis on sexual dimorphism in response to COVID-19 vaccination are relatively scarce ...
Janneke W. Duijster   +8 more
doaj   +1 more source

Model estimates of hospitalization discharge rates for norovirus gastroenteritis in Europe, 2004–2015

open access: yesBMC Infectious Diseases, 2021
Background Norovirus is an important cause of acute gastroenteritis globally. However, norovirus is rarely laboratory confirmed or recorded explicitly as a cause of hospitalization.
Elsa Negro-Calduch   +2 more
doaj   +1 more source

Audits and inspections of pharmacovigilance systems in Russia

open access: yesКачественная клиническая практика, 2023
The implementation of pharmacovigilance activities is impossible in isolation from compliance with the quality requirements of medicines and the activities of pharmaceutical and medical organizations throughout the pharmaceutical practice, as well as ...
A. A. Taube, B. K. Romanov
doaj   +1 more source

Research Progress of Antitumor Pharmacovigilance

open access: yesChinese Journal of Lung Cancer, 2022
In 2019, Drug Administration Law of China was first time proposed that the country should establish pharmacovigilance system. In 2021, the first Pharmacovigilance Quality Management Standard of China was released.
Wenjuan SUN, Yang HU, Yan XU, Bo ZHANG
doaj   +1 more source

Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey

open access: yesDrugs in R&D, 2018
Background We report on the results of a Japanese postmarketing drug-use survey of suvorexant (Belsomra®) tablets. Methods A survey with a ≤ 6-month observation period after the start of administration was conducted, targeting insomnia patients who were ...
Yuko Asai   +5 more
doaj   +1 more source

Pharmacovigilance in oncology [PDF]

open access: yesInternational Journal of Clinical Pharmacy, 2018
AbstractBackground Side effects of cancer therapy are one of the most important issues faced by cancer patients during their illness. Pharmacovigilance, namely the science and activities aimed at monitoring the safety of drugs, is particularly important in oncology, due to the intrinsic biologic toxicity of antineoplastic agents, their narrow ...
Paolo Baldo   +4 more
openaire   +2 more sources

Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan

open access: yesInfectious Diseases and Therapy, 2023
Introduction Molnupiravir is an oral antiviral drug that received special approval for emergency use in Japan on December 24 2021 for infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Masahiro Kimata   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy